RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment ...

RxDx Device for non-small cell lung cancer has received Breakthrough Device Designation from the U.S. Food and Drug ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

The global malignant pleural effusion market will likely reach a valuation of USD 8.06 billion by 2033, rising from USD 4.5 billion in 2023. The market is slated to grow at a positive CAGR of 6% from ...

A new Stanford blood test detects cancer and tissue damage by analyzing rare RNA fragments in the blood. Stanford Medicine ...

The device helps identify NSCLC subjects who are likely to benefit from Daiichi Sankyo and AstraZeneca’s Datroway’s treatment ...

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based ...

Mapping a tumor's cellular neighborhood in three dimensions could identify potential targets for personalized cancer therapy.

Online trolls had recently suggested that Kellie was lying about her diagnosis, comparing her to notorious 'cancer faker' ...

A 26-year-old Mammoth Mountain employee died from hantavirus. An investigation found mice droppings at the hotel where he ...

In solid tumors, such as skin, lung, or bone and soft tissue cancer ... New Immune Boost Could Expand Access to Cancer Immunotherapy Apr. 11, 2025 — Researchers have found that tapping into the ...